AIT Laboratories has named Scott LaNeve as its vice president of sales and marketing. LaNeve brings to the company 30 years of general management and commercial leadership experience from a broad spectrum of healthcare companies including Fortune 100 market leaders such as Abbott Laboratories, Roche and Quest Diagnostics. LaNeve spent the past eight years assisting small start-ups and mid-market companies, concentrating on commercial turnarounds. LaNeve's extensive experience and knowledge in diagnostics, marketing and global sales uniquely leverages AIT's performance in every market segment, customer type and commercial challenge found in healthcare.

Chronic pain affects an estimated 116 million adults in the U.S.--more than the number affected by heart disease, diabetes, and cancer combined, according to a recent report by the Institute of Medicine. At the same time, prescriptions for opioids have increased over the last ten years by 48%, contributing to the nation's growing battle with prescription drug abuse, according to a report by the U.S. Food and Drug Administration. As a result, healthcare practitioners treating patients with chronic pain are in need of services to help manage the care of their patients while making sure that patients are compliant with their prescribed medications. American Institute of Toxicology, Inc. is launching AIT Pathways, a new suite of services for prescription compliance monitoring that provides data and information to healthcare practitioners who are trying to find a balance between safety, efficacy, and risk in order to meet their patients' needs.